Jose Antonio Seoane
Jose Antonio Seoane
Junior Group Leader at VHIO
Verified email at
Cited by
Cited by
Integrated genomic characterization of oesophageal carcinoma
Cancer Genome Atlas Research Network
Nature 541 (7636), 169, 2017
The chromatin accessibility landscape of primary human cancers
MR Corces, JM Granja, S Shams, BH Louie, JA Seoane, W Zhou, ...
Science 362 (6413), eaav1898, 2018
Comparative molecular analysis of gastrointestinal adenocarcinomas
Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ...
Cancer cell 33 (4), 721-735. e8, 2018
Quantitative evidence for early metastatic seeding in colorectal cancer
Z Hu, J Ding, Z Ma, R Sun, JA Seoane, J Scott Shaffer, CJ Suarez, ...
Nature genetics 51 (7), 1113-1122, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ...
Nature 567 (7748), 399-404, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ...
Nature communications 10 (1), 2674, 2019
Classification of EEG signals using relative wavelet energy and artificial neural networks
L Guo, D Rivero, JA Seoane, A Pazos
Proceedings of the first ACM/SIGEVO Summit on Genetic and Evolutionary …, 2009
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
K Han, SE Pierce, A Li, K Spees, GR Anderson, JA Seoane, YH Lo, ...
Nature 580 (7801), 136-141, 2020
A p53 super-tumor suppressor reveals a tumor suppressive p53-Ptpn14-Yap axis in pancreatic cancer
SS Mello, LJ Valente, N Raj, JA Seoane, BM Flowers, J McClendon, ...
Cancer cell 32 (4), 460-473. e6, 2017
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
ZN Rogers, CD McFarland, IP Winters, JA Seoane, JJ Brady, S Yoon, ...
Nature genetics 50 (4), 483-486, 2018
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis
RA Kamber, Y Nishiga, B Morton, AM Banuelos, AA Barkal, ...
Nature 597 (7877), 549-554, 2021
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
YH Lo, KS Kolahi, Y Du, CY Chang, A Krokhotin, A Nair, WD Sobba, ...
Cancer discovery 11 (6), 1562-1581, 2021
The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D
AC Chaikovsky, C Li, EE Jeng, S Loebell, MC Lee, CW Murray, R Cheng, ...
Nature 592 (7856), 794-798, 2021
A pathway-based data integration framework for prediction of disease progression
JA Seoane, INM Day, TR Gaunt, C Campbell
Bioinformatics 30 (6), 838-845, 2014
Drug discovery and design for complex diseases through QSAR computational methods
C R Munteanu, E Fernández-Blanco, J A Seoane, P Izquierdo-Novo, ...
Current pharmaceutical design 16 (24), 2640-2655, 2010
Cell of origin influences pancreatic cancer subtype
BM Flowers, H Xu, AS Mulligan, KJ Hanson, JA Seoane, H Vogel, ...
Cancer discovery 11 (3), 660-677, 2021
The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
Y Xiao, KN Thakkar, H Zhao, J Broughton, Y Li, JA Seoane, AN Diep, ...
Proceedings of the National Academy of Sciences 117 (35), 21441-21449, 2020
Metabolic profiling reveals a dependency of human metastatic breast cancer on mitochondrial serine and one-carbon unit metabolism
AM Li, GS Ducker, Y Li, JA Seoane, Y Xiao, S Melemenidis, Y Zhou, L Liu, ...
Molecular Cancer Research 18 (4), 599-611, 2022
RRegrs: an R package for computer-aided model selection with multiple regression models
G Tsiliki, CR Munteanu, JA Seoane, C Fernandez-Lozano, H Sarimveis, ...
Journal of cheminformatics 7, 1-16, 2015
Zmat3 is a key splicing regulator in the p53 tumor suppression program
KT Bieging-Rolett, AM Kaiser, DW Morgens, AM Boutelle, JA Seoane, ...
Molecular cell 80 (3), 452-469. e9, 2020
The system can't perform the operation now. Try again later.
Articles 1–20